BNP-1350
Also known as: Gut Barrier Peptide, Intestinal Peptide
A peptide being researched for inflammatory bowel disease and gut barrier function.
Overview
BNP-1350 is a research peptide being investigated for its effects on gut barrier integrity and inflammation in the context of inflammatory bowel disease. It represents a class of peptides targeting the gut-immune axis.
Mechanism of Action
Modulates inflammatory pathways in intestinal mucosa. Supports epithelial barrier function and reduces pro-inflammatory cytokine production in gut tissue.
Pharmacokinetics
Research compound with GI-focused effects. Administration routes under investigation.
Dosing Protocols
Note: These are research protocols from literature. This is not medical advice.
Research
Variable
Variable
Variable
Experimental protocols
Research Areas
Key Research Findings
- 1Anti-inflammatory effects in gut tissue
- 2Supports epithelial barrier integrity
- 3Research stage compound
- 4Targets gut-immune axis
Side Effects & Contraindications
Reported Side Effects
- Under investigation
Contraindications
- Research compound - limited data
Safety Considerations
Research compound with limited human safety data. Ongoing preclinical and early clinical studies.
Storage Requirements
Store at -20C
Scientific References
- 1